{"id":"https://openalex.org/W2810002197","doi":"https://doi.org/10.1186/s12967-018-1563-y","title":"Long term impact of CTLA4 blockade immunotherapy on regulatory and effector immune responses in patients with melanoma","display_name":"Long term impact of CTLA4 blockade immunotherapy on regulatory and effector immune responses in patients with melanoma","alternate_titles":[],"publication_year":2018,"publication_date":"2018-07-04","ids":{"openalex":"https://openalex.org/W2810002197","doi":"https://doi.org/10.1186/s12967-018-1563-y","mag":"2810002197","pmid":"https://pubmed.ncbi.nlm.nih.gov/29973204","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6033230"},"language":"en","primary_location":{"id":"doi:10.1186/s12967-018-1563-y","doi":"https://doi.org/10.1186/s12967-018-1563-y","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12967-018-1563-y","pdf_url":"https://translational-medicine.biomedcentral.com/counter/pdf/10.1186/s12967-018-1563-y","source":{"id":"https://openalex.org/S142026636","display_name":"Journal of Translational Medicine","issn_l":"1479-5876","issn":["1479-5876"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-2","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Translational Medicine","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2810002197"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://translational-medicine.biomedcentral.com/counter/pdf/10.1186/s12967-018-1563-y","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057211811","display_name":"Janet Retseck","orcid":"https://orcid.org/0009-0009-4911-4803","observed_orcids":["https://orcid.org/0009-0009-4911-4803"]},"institutions":[{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Janet Retseck","raw_affiliation_strings":["University of Pittsburgh Cancer Institute, Pittsburgh, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pittsburgh Cancer Institute, Pittsburgh, USA","institution_ids":["https://openalex.org/I4210128526"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Alexis Nasr","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alexis Nasr","raw_affiliation_strings":["University of Pittsburgh Cancer Institute, Pittsburgh, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pittsburgh Cancer Institute, Pittsburgh, USA","institution_ids":["https://openalex.org/I4210128526"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022244759","display_name":"Yan Lin","orcid":"https://orcid.org/0000-0001-8034-5946","observed_orcids":["https://orcid.org/0000-0001-8034-5946"]},"institutions":[{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yan Lin","raw_affiliation_strings":["University of Pittsburgh Cancer Institute, Pittsburgh, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pittsburgh Cancer Institute, Pittsburgh, USA","institution_ids":["https://openalex.org/I4210128526"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100393792","display_name":"Lin Huang","orcid":"https://orcid.org/0000-0002-4892-7871","observed_orcids":["https://orcid.org/0000-0002-4892-7871"]},"institutions":[{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Huang Lin","raw_affiliation_strings":["University of Pittsburgh Cancer Institute, Pittsburgh, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pittsburgh Cancer Institute, Pittsburgh, USA","institution_ids":["https://openalex.org/I4210128526"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062453358","display_name":"Prateek Mendiratta","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Prateek Mendiratta","raw_affiliation_strings":["Department of Hematology and Oncology, Cleveland Clinic Taussig Cancer Institute, 9500 Euclid Ave CA6-157, Cleveland, OH, 44195, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Oncology, Cleveland Clinic Taussig Cancer Institute, 9500 Euclid Ave CA6-157, Cleveland, OH, 44195, USA","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026029856","display_name":"Lisa Helene Butterfield","orcid":"https://orcid.org/0000-0002-3439-9844","observed_orcids":["https://orcid.org/0000-0002-3439-9844"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]},{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]},{"id":"https://openalex.org/I4210134769","display_name":"University of Pittsburgh Medical Center","ror":"https://ror.org/04ehecz88","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210098814","https://openalex.org/I4210134769"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lisa H. Butterfield","raw_affiliation_strings":["Departments of Medicine, Surgery and Immunology, University of Pittsburgh School of Medicine, UPMC Hillman Cancer Center, Pittsburgh, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicine, Surgery and Immunology, University of Pittsburgh School of Medicine, UPMC Hillman Cancer Center, Pittsburgh, USA","institution_ids":["https://openalex.org/I170201317","https://openalex.org/I4210128526","https://openalex.org/I4210134769"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5020955148","display_name":"Ahmad A. Tarhini","orcid":"https://orcid.org/0000-0002-3193-9702","observed_orcids":["https://orcid.org/0000-0002-3193-9702"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]},{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]},{"id":"https://openalex.org/I4390039247","display_name":"Case Comprehensive Cancer Center","ror":"https://ror.org/00fpjq451","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039247","https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Ahmad A. Tarhini","raw_affiliation_strings":["Case Comprehensive Cancer Center, Cleveland, USA. tarhina1@ccf.org","Department of Hematology and Oncology, Cleveland Clinic Taussig Cancer Institute, 9500 Euclid Ave CA6-157, Cleveland, OH, 44195, USA. tarhina1@ccf.org","University of Pittsburgh Cancer Institute, Pittsburgh, USA. tarhina1@ccf.org","Department of Hematology and Oncology, Cleveland Clinic Taussig Cancer Institute, 9500 Euclid Ave CA6-157, Cleveland, OH, 44195, USA"],"raw_orcid":"https://orcid.org/0000-0002-3193-9702","affiliations":[{"raw_affiliation_string":"Case Comprehensive Cancer Center, Cleveland, USA. tarhina1@ccf.org","institution_ids":["https://openalex.org/I4390039247"]},{"raw_affiliation_string":"Department of Hematology and Oncology, Cleveland Clinic Taussig Cancer Institute, 9500 Euclid Ave CA6-157, Cleveland, OH, 44195, USA. tarhina1@ccf.org","institution_ids":["https://openalex.org/I1316902750"]},{"raw_affiliation_string":"University of Pittsburgh Cancer Institute, Pittsburgh, USA. tarhina1@ccf.org","institution_ids":["https://openalex.org/I4210128526"]},{"raw_affiliation_string":"Department of Hematology and Oncology, Cleveland Clinic Taussig Cancer Institute, 9500 Euclid Ave CA6-157, Cleveland, OH, 44195, USA","institution_ids":["https://openalex.org/I1316902750"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5020955148"],"corresponding_institution_ids":["https://openalex.org/I1316902750","https://openalex.org/I4210128526","https://openalex.org/I4390039247"],"apc_list":{"value":3890,"currency":"USD","value_usd":3890},"apc_paid":{"value":3890,"currency":"USD","value_usd":3890},"fwci":1.9988,"has_fulltext":true,"cited_by_count":54,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.89598626,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"16","issue":"1","first_page":"184","last_page":"184"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ctla-4-blockade","display_name":"CTLA-4 blockade","score":0.9559999704360962},{"id":"https://openalex.org/keywords/ipilimumab","display_name":"ipilimumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.9729999899864197},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.9629999995231628},{"id":"https://openalex.org/keywords/myeloid-derived-suppressor-cells","display_name":"myeloid-derived suppressor cells","score":0.9300000071525574},{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.7519999742507935},{"id":"https://openalex.org/keywords/antigen-specific-t-cells","display_name":"antigen-specific T cells","score":0.7099999785423279},{"id":"https://openalex.org/keywords/ny-eso-1","display_name":"NY-ESO-1","score":0.9100000262260437},{"id":"https://openalex.org/keywords/melan-a","display_name":"Melan-A","score":0.9380000233650208},{"id":"https://openalex.org/keywords/gp100","display_name":"gp100","score":0.9769999980926514},{"id":"https://openalex.org/keywords/cancer-testis-antigens","display_name":"cancer-testis antigens","score":0.8799999952316284},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.8629999756813049},{"id":"https://openalex.org/keywords/cd69","display_name":"CD69","score":0.7160000205039978},{"id":"https://openalex.org/keywords/relapse-free-survival","display_name":"relapse-free survival","score":0.8830000162124634},{"id":"https://openalex.org/keywords/neoadjuvant-immunotherapy","display_name":"neoadjuvant immunotherapy","score":0.8659999966621399}],"concepts":[{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.7481246590614319},{"id":"https://openalex.org/C51785407","wikidata":"https://www.wikidata.org/wiki/Q2627568","display_name":"Effector","level":2,"score":0.7163808345794678},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.7161057591438293},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.6729286909103394},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.606304943561554},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5401429533958435},{"id":"https://openalex.org/C61797465","wikidata":"https://www.wikidata.org/wiki/Q1188986","display_name":"Term (time)","level":2,"score":0.5330504179000854},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5060428977012634},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.4704740643501282},{"id":"https://openalex.org/C21705690","wikidata":"https://www.wikidata.org/wiki/Q2907609","display_name":"CTLA-4","level":4,"score":0.453251451253891},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3160008192062378},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.18556609749794006},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.16679051518440247},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.09148001670837402},{"id":"https://openalex.org/C62520636","wikidata":"https://www.wikidata.org/wiki/Q944","display_name":"Quantum mechanics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000074324","descriptor_name":"Ipilimumab","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007109","descriptor_name":"Immunity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020360","descriptor_name":"Neoadjuvant Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D050378","descriptor_name":"T-Lymphocytes, Regulatory","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D060908","descriptor_name":"CTLA-4 Antigen","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D060908","descriptor_name":"CTLA-4 Antigen","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1186/s12967-018-1563-y","doi":"https://doi.org/10.1186/s12967-018-1563-y","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12967-018-1563-y","pdf_url":"https://translational-medicine.biomedcentral.com/counter/pdf/10.1186/s12967-018-1563-y","source":{"id":"https://openalex.org/S142026636","display_name":"Journal of Translational Medicine","issn_l":"1479-5876","issn":["1479-5876"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-2","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Translational Medicine","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:4994245","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC6033230","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6033230","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6033230/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Transl Med","raw_type":"Text"},{"id":"pmid:29973204","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29973204","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of translational medicine","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:80318e8961ff47eeb534cc9151dee8db","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/80318e8961ff47eeb534cc9151dee8db","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-11 (2018)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1186/s12967-018-1563-y","doi":"https://doi.org/10.1186/s12967-018-1563-y","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12967-018-1563-y","pdf_url":"https://translational-medicine.biomedcentral.com/counter/pdf/10.1186/s12967-018-1563-y","source":{"id":"https://openalex.org/S142026636","display_name":"Journal of Translational Medicine","issn_l":"1479-5876","issn":["1479-5876"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-2","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Translational Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1178683247","display_name":null,"funder_award_id":"P30CA047904","funder_id":"https://openalex.org/F4320306080","funder_display_name":"Foundation for the National Institutes of Health"},{"id":"https://openalex.org/G3072520134","display_name":null,"funder_award_id":"CA184-082","funder_id":"https://openalex.org/F4320307115","funder_display_name":"Bristol-Myers Squibb"},{"id":"https://openalex.org/G5686869940","display_name":"SPORE in Skin Cancer","funder_award_id":"P50CA121973","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G8075856692","display_name":null,"funder_award_id":"P50 CA121973","funder_id":"https://openalex.org/F4320306080","funder_display_name":"Foundation for the National Institutes of Health"},{"id":"https://openalex.org/G9000897317","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA047904","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320306080","display_name":"Foundation for the National Institutes of Health","ror":"https://ror.org/00k86s890"},{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332713","display_name":"Cancer Institute, University of Pittsburgh","ror":"https://ror.org/01an3r305"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2810002197.pdf","grobid_xml":"https://content.openalex.org/works/W2810002197.grobid-xml"},"referenced_works_count":54,"referenced_works":["https://openalex.org/W1484130254","https://openalex.org/W1536480181","https://openalex.org/W1585754595","https://openalex.org/W1828940258","https://openalex.org/W1908752382","https://openalex.org/W1916595094","https://openalex.org/W1927075449","https://openalex.org/W1951046932","https://openalex.org/W1966140800","https://openalex.org/W1971595657","https://openalex.org/W1976157528","https://openalex.org/W1981528932","https://openalex.org/W1990123659","https://openalex.org/W2004150448","https://openalex.org/W2005251163","https://openalex.org/W2011564612","https://openalex.org/W2015085911","https://openalex.org/W2016685578","https://openalex.org/W2021218996","https://openalex.org/W2024832944","https://openalex.org/W2035464744","https://openalex.org/W2038918212","https://openalex.org/W2049126749","https://openalex.org/W2055901890","https://openalex.org/W2061071534","https://openalex.org/W2064607012","https://openalex.org/W2075326745","https://openalex.org/W2078132657","https://openalex.org/W2080886891","https://openalex.org/W2090672759","https://openalex.org/W2097995306","https://openalex.org/W2102862705","https://openalex.org/W2110440135","https://openalex.org/W2113266244","https://openalex.org/W2114329158","https://openalex.org/W2118449798","https://openalex.org/W2119077297","https://openalex.org/W2123264723","https://openalex.org/W2133075384","https://openalex.org/W2134638467","https://openalex.org/W2139191751","https://openalex.org/W2142263069","https://openalex.org/W2146437446","https://openalex.org/W2151957163","https://openalex.org/W2154404342","https://openalex.org/W2161550811","https://openalex.org/W2162646864","https://openalex.org/W2167866281","https://openalex.org/W2172131454","https://openalex.org/W2266683146","https://openalex.org/W2317575649","https://openalex.org/W2330359038","https://openalex.org/W2529373149","https://openalex.org/W2607052590"],"related_works":["https://openalex.org/W2561212718","https://openalex.org/W2246004191","https://openalex.org/W1506945254","https://openalex.org/W2470428689","https://openalex.org/W2103170395","https://openalex.org/W2345485155","https://openalex.org/W1977991856","https://openalex.org/W2318283068","https://openalex.org/W2398196557","https://openalex.org/W1974892500"],"abstract_inverted_index":{"BACKGROUND:":[0],"We":[1,86,100,224],"previously":[2],"reported":[3],"early":[4],"on-treatment":[5],"significant":[6,152],"modulation":[7],"in":[8,33,154,198,252],"circulating":[9,104,173,190],"regulatory":[10],"T":[11,26,120,238],"cell":[12,239],"(Treg),":[13],"myeloid":[14],"derived":[15],"suppressor":[16],"cells":[17,27,121],"(MDSC)":[18],"and":[19,24,78,93,106,118,159,202,235,266,271,290,307,325],"antigen-specific":[20,237],"type":[21,228],"I":[22,229],"CD4+":[23,117,234],"CD8+":[25,119,236],"that":[28],"correlated":[29],"with":[30,39,57,150,179,288,305,322],"clinical":[31],"outcome":[32],"regionally":[34],"advanced":[35],"melanoma":[36],"patients":[37],"treated":[38,56],"neoadjuvant":[40],"ipilimumab.":[41,278,314],"Here,":[42],"we":[43],"investigated":[44],"the":[45,199,209,253,275],"long":[46],"term":[47],"immunologic":[48],"impact":[49],"of":[50,103,116,132,172,189,227,255,277],"CTLA4":[51,295,323],"blockade.":[52],"METHODS:":[53],"Patients":[54],"were":[55,74,176,194,260,310],"ipilimumab":[58,142],"given":[59],"at":[60,76,90,138,162,196,205,218,263,268,283],"10":[61],"mg/kg":[62],"IV":[63],"every":[64],"3":[65,148],"weeks":[66,140,265],"for":[67,81],"2":[68],"doses":[69],"bracketing":[70],"surgery.":[71],"Blood":[72],"specimens":[73],"collected":[75],"baseline":[77,110,146,170,197,284],"during":[79],"treatment":[80],"up":[82],"to":[83,109,123,145,327],"9":[84,94,166,222,272],"months.":[85,167,223],"tested":[87],"immune":[88,318],"responses":[89,259,319],"3,":[91,163,219,269],"6,":[92],"months":[95,273],"utilizing":[96],"multicolor":[97],"flow":[98],"cytometry.":[99],"compared":[101],"frequencies":[102,115],"Treg":[105,133,155,174,281,292],"MDSC":[107,193,301,308],"on-study":[108],"levels,":[111],"as":[112,114,244,246],"well":[113,245],"specific":[122,316],"shared":[124],"tumor-associated":[125],"antigens":[126,251],"(Gp-100,":[127],"MART-1,":[128],"NY-ESO-1).":[129],"RESULTS:":[130],"Levels":[131,188],"significantly":[134,177,261,286],"increased":[135,291],"when":[136],"measured":[137],"6":[139,164,206,220,264,270],"following":[141,274],"but":[143],"returned":[144],"by":[147],"months,":[149],"no":[151],"difference":[153],"levels":[156,171,282,309],"between":[157],"relapsed":[158],"relapse-free":[160,200],"groups":[161],"or":[165,221],"However,":[168],"lower":[169,195],"(CD4+CD25hi+CD39+)":[175],"associated":[178,287,304],"better":[180],"relapse":[181],"free":[182],"survival":[183],"(RFS)":[184],"(p":[185],"=":[186],"0.04).":[187],"monocytic":[191],"HLA-DR+/loCD14+":[192],"group":[201],"further":[203,311],"decreased":[204,312],"weeks,":[207],"though":[208],"differences":[210],"did":[211],"not":[212],"reach":[213],"statistical":[214],"significance":[215],"including":[216],"measurements":[217],"detected":[225],"evidence":[226],"(interferon-\u03b3":[230],"producing),":[231],"activated":[232],"(CD69+)":[233],"immunity":[240],"against":[241],"cancer-testis":[242],"(NY-ESO-1)":[243],"melanocytic":[247],"lineage":[248],"(MART-1,":[249],"gp100)":[250],"absence":[254],"therapeutic":[256],"vaccination.":[257],"These":[258],"boosted":[262,321],"persisted":[267],"initiation":[276],"CONCLUSIONS:":[279],"Lower":[280,300],"are":[285,320],"RFS":[289,306],"frequency":[293],"after":[294,313],"blockade":[296,324],"was":[297,302],"only":[298],"transient.":[299],"also":[303],"Tumor":[315],"effector":[317],"tend":[326],"be":[328],"durable.":[329],"Trial":[330],"registration":[331],"ClinicalTrials.gov":[332],"Identifier:":[333],"NCT00972933.":[334]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2810002197","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":9},{"year":2019,"cited_by_count":4},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2018-07-10T00:00:00"}
